ZEB2 inhibits HBV transcription and replication by targeting its core promoter
Qiao He(Qilu Hospital of Shandong University), Weixian Chen(Dalian Medical University)
Cited by 19
Related Papers
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
|Alzheimer s Research & Therapy|2021|200
Streptococcus pneumoniae Induces Autophagy through the Inhibition of the PI3K-I/Akt/mTOR Pathway and ROS Hypergeneration in A549 Cells
|PLoS ONE|2015|72
E-cadherin Plays a Role in Hepatitis B Virus Entry Through Affecting Glycosylated Sodium-Taurocholate Cotransporting Polypeptide Distribution
|Frontiers in Cellular and Infection Microbiology|2020|38
A multifunctional DNA nano-scorpion for highly efficient targeted delivery of mRNA therapeutics
|Scientific Reports|2018|20
Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases
|Journal of Translational Medicine|2018|14